Sabra Health Care REIT Inc (NASDAQ:SBRA) issued an update on its FY17 earnings guidance on Monday morning. The company provided earnings per share guidance of $2.19 – $2.23 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.34.
Shares of Sabra Health Care REIT Inc (NASDAQ:SBRA) traded up 0.46% during trading on Friday, hitting $24.17. 440,494 shares of the company were exchanged. Sabra Health Care REIT Inc has a 12 month low of $19.30 and a 12 month high of $29.10. The stock has a market cap of $1.58 billion, a P/E ratio of 16.70 and a beta of 1.10. The company’s 50-day moving average price is $26.96 and its 200 day moving average price is $25.21.
Sabra Health Care REIT (NASDAQ:SBRA) last posted its quarterly earnings data on Monday, May 8th. The real estate investment trust reported $0.25 EPS for the quarter, missing the Zacks’ consensus estimate of $0.58 by $0.33. The company had revenue of $62.65 million during the quarter, compared to analyst estimates of $63.47 million. Sabra Health Care REIT had a return on equity of 7.05% and a net margin of 27.18%. Sabra Health Care REIT’s revenue was up .1% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.54 earnings per share. On average, equities analysts predict that Sabra Health Care REIT Inc will post $1.20 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 31st. Investors of record on Thursday, May 18th will be paid a $0.43 dividend. This is a positive change from Sabra Health Care REIT’s previous quarterly dividend of $0.42. This represents a $1.72 dividend on an annualized basis and a dividend yield of 7.15%. The ex-dividend date of this dividend is Tuesday, May 16th. Sabra Health Care REIT’s payout ratio is currently 178.72%.
A number of equities analysts recently commented on the company. Zacks Investment Research lowered Sabra Health Care REIT from a buy rating to a hold rating in a research note on Tuesday, January 24th. Cantor Fitzgerald reaffirmed a buy rating and issued a $30.00 price objective on shares of Sabra Health Care REIT in a research note on Monday, May 8th. Jefferies Group LLC reaffirmed a hold rating and issued a $25.00 price objective on shares of Sabra Health Care REIT in a research note on Tuesday, January 31st. Mizuho reaffirmed a neutral rating and issued a $28.00 price objective (up from $22.00) on shares of Sabra Health Care REIT in a research note on Monday, February 27th. Finally, Canaccord Genuity reaffirmed a hold rating and issued a $26.00 price objective on shares of Sabra Health Care REIT in a research note on Tuesday, May 9th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the stock. The company has an average rating of Hold and an average target price of $27.38.
Sabra Health Care REIT Company Profile
Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.
Receive News & Ratings for Sabra Health Care REIT Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT Inc and related companies with MarketBeat.com's FREE daily email newsletter.